MannKind Corporation (NASDAQ:MNKD) and BIOMM announced the submission of a registration dossier to ANVISA, seeking the approval of Afrezza® (insulin human) inhalation powder …
Healthcare analysts take different approaches to valuing Transenterix and Valeant.
Hartaj Singh believes QURE trots out an upper hand advantage with AMT-061.
Friday turned out to be a nightmare for DURECT Corporation (NASDAQ:DRRX) investors, after the drug maker announced that its pain relief candidate Posimir failed …
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are rising nearly 4% in pre-market trading Friday, after the drug maker announced plans to expand its voclosoprin renal …
Cowen always deemed CELG’s failed drug a risky contender, welcomes GILD’s full approval for Yescarta.
Omeros Corporation (NASDAQ:OMER) announced the presentation of a case report of a patient having co-existing hematopoietic stem cell transplant-associated thrombotic microangiopathy (HCT-TMA) and …
Louise Chen anticipates more generic pricing pressure hit 3Q earnings for generic manufacturers.
Uniqure NV is back in the race for a hemophilia B gene therapy.
Did this $4 billion fund make the right call on these two soaring biotechs?